Congress Asset Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-63,813	Closed	-$3.34M	–	346
2019 Q3	$3.34M	Buy	63,813 +3,353	+6%	+$156K	0.04%	227
2019 Q2	$2.92M	Sell	60,460 -12,698	-17%	-$609K	0.04%	245
2019 Q1	$3.7M	Sell	73,158 -1,715	-2%	-$101K	0.05%	217
2018 Q4	$4.44M	Sell	74,873 -8,248	-10%	-$532K	0.07%	166
2018 Q3	$5.47M	Sell	83,121 -4,861	-6%	-$284K	0.07%	178
2018 Q2	$4.44M	Buy	87,982 +3,251	+4%	+$169K	0.06%	194
2018 Q1	$4.46M	Buy	84,731 +23,168	+38%	+$1.15M	0.06%	188
2017 Q4	$2.86M	Buy	61,563 +3,507	+6%	+$148K	0.04%	227
2017 Q3	$2.35M	Buy	58,056 +5,976	+11%	+$216K	0.04%	236
2017 Q2	$1.77M	Buy	52,080 +4,632	+10%	+$143K	0.03%	177
2017 Q1	$1.38M	Buy	47,448 +30,824	+185%	+$938K	0.03%	185
2016 Q4	$546K	Buy	16,624 +9,819	+144%	+$294K	0.01%	200
2016 Q3	$215K	Buy	+6,805	New	+$198K	﹤0.01%	244